https://prabadinews.com/
  • October 7, 2026
  • Last Update July 17, 2026 9:28 pm
  • United States of America

FDA Approves Pegcetacoplan to Reduce Proteinuria in 2 Kidney-Related Diseases

FDA Approves Pegcetacoplan to Reduce Proteinuria in 2 Kidney-Related Diseases

The treatment proved efficacy across all 3 key markers of C3 glomerulopathy (C3G) and primary immune complex membranoproliferative glomerulonephritis (IC-MPGN).

administrator

Related Articles